Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dasatinib | 1 | 2020 | 58 | 0.610 |
Why?
|
| Brain Stem Neoplasms | 1 | 2020 | 87 | 0.590 |
Why?
|
| Brain Neoplasms | 5 | 2025 | 1329 | 0.420 |
Why?
|
| Laser Therapy | 2 | 2025 | 144 | 0.350 |
Why?
|
| Glioma | 2 | 2025 | 429 | 0.290 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2214 | 0.280 |
Why?
|
| Dog Diseases | 1 | 2025 | 86 | 0.210 |
Why?
|
| Radiation Injuries | 1 | 2022 | 149 | 0.160 |
Why?
|
| Convection | 1 | 2020 | 7 | 0.160 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2019 | 12 | 0.150 |
Why?
|
| Epidural Abscess | 1 | 2019 | 7 | 0.150 |
Why?
|
| Quinolines | 1 | 2020 | 190 | 0.140 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 160 | 0.140 |
Why?
|
| Conservative Treatment | 1 | 2019 | 45 | 0.140 |
Why?
|
| Ficusin | 1 | 2017 | 6 | 0.130 |
Why?
|
| Radiosurgery | 1 | 2022 | 399 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2020 | 365 | 0.130 |
Why?
|
| Pituitary Neoplasms | 1 | 2019 | 190 | 0.130 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2017 | 35 | 0.130 |
Why?
|
| Phototherapy | 1 | 2017 | 49 | 0.130 |
Why?
|
| Photosensitizing Agents | 1 | 2017 | 42 | 0.130 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 244 | 0.130 |
Why?
|
| Melanoma, Experimental | 1 | 2017 | 109 | 0.130 |
Why?
|
| Major Histocompatibility Complex | 1 | 2017 | 233 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 467 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2188 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2019 | 666 | 0.110 |
Why?
|
| Histones | 1 | 2020 | 666 | 0.110 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 1996 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 1505 | 0.090 |
Why?
|
| Cell Degranulation | 1 | 2011 | 40 | 0.090 |
Why?
|
| Arginase | 1 | 2011 | 26 | 0.090 |
Why?
|
| Apoptosis | 1 | 2020 | 2440 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2011 | 385 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 439 | 0.070 |
Why?
|
| Mice | 3 | 2020 | 18329 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2011 | 353 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3904 | 0.060 |
Why?
|
| Animals | 4 | 2025 | 38030 | 0.060 |
Why?
|
| Neutrophils | 1 | 2011 | 1124 | 0.060 |
Why?
|
| Dogs | 1 | 2025 | 458 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4560 | 0.040 |
Why?
|
| Humans | 8 | 2025 | 145475 | 0.040 |
Why?
|
| Lasers | 1 | 2022 | 126 | 0.040 |
Why?
|
| Neurosurgeons | 1 | 2021 | 17 | 0.040 |
Why?
|
| Steroids | 1 | 2022 | 160 | 0.040 |
Why?
|
| Necrosis | 1 | 2022 | 244 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 70 | 0.040 |
Why?
|
| Biopsy | 1 | 2022 | 1082 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2017 | 75 | 0.030 |
Why?
|
| Adenoma | 1 | 2019 | 218 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2017 | 204 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1266 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1149 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 2090 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 1100 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 1111 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3542 | 0.020 |
Why?
|
| Arginine | 1 | 2011 | 264 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2011 | 274 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 8057 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 5983 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 7123 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 8333 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 40777 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 36215 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 11772 | 0.020 |
Why?
|
| Female | 3 | 2019 | 78845 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 4148 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 17291 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 14219 | 0.010 |
Why?
|
| Male | 2 | 2019 | 72843 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 22530 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 26153 | 0.010 |
Why?
|